NCT05272787View on ClinicalTrials.gov

Clinical Trial to Evaluate Safety and Efficacy of a Facial and Lip Moisturizer in Adult Subjects Undergoing a Facial Dermatologic Procedure With Fractional CO2 Laser

NACompletedINTERVENTIONAL
Enrollment

35

Participants

Timeline

Start Date

March 10, 2022

Primary Completion Date

April 13, 2022

Study Completion Date

June 16, 2022

Conditions
Skin Regeneration After Dermatological Facial Procedure With Fractional CO2 Laser
Interventions
OTHER

TH Facial Moisturizer

All subjects will receive all the products. There will be a supervised application at the site on the baseline visit of the study. Then subjects will use all the products at home.

OTHER

TH Lip Moisturizer

All subjects will receive all the products. There will be a supervised application at the site on the baseline visit of the study. Then subjects will use all the products at home.

OTHER

Facial Moisturizer B (Control)

All subjects will receive all the products. There will be a supervised application at the site on the baseline visit of the study. Then subjects will use all the products at home.

OTHER

Sunscreen

Auxiliary product

OTHER

Facial wash

Auxiliary product.

Trial Locations (1)

13084-791

Allergisa Pesquisa Dermato-Cosmetica Ltda, Campinas

All Listed Sponsors
lead

Johnson & Johnson Consumer Inc. (J&JCI)

INDUSTRY

NCT05272787 - Clinical Trial to Evaluate Safety and Efficacy of a Facial and Lip Moisturizer in Adult Subjects Undergoing a Facial Dermatologic Procedure With Fractional CO2 Laser | Biotech Hunter | Biotech Hunter